Editorial: Tardive dyskinesias.
D000328:Adult; D000367:Age Factors; D000368:Aged; D001008:Anxiety Disorders / Q000188:drug therapy; D002746:Chlorpromazine / Q000009:adverse effects; D002908:Chronic Disease; D005260:Female; D005756:Gastritis / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced*; D011346:Prochlorperazine / Q000009:adverse effects; D013881:Thioridazine / Q000009:adverse effects; D013997:Time Factors; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014268:Trifluoperazine / Q000009:adverse effects
D014149:Tranquilizing Agents; D014268:Trifluoperazine; D013881:Thioridazine; D002746:Chlorpromazine; D011346:Prochlorperazine